MetaCap

Pediatrix Medical Group Financial Ratios

NYSE: MDHealth CareHospital/Nursing ManagementUSD

26.64+0.40 (+1.52%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Pediatrix Medical Group ratio analysis

Pediatrix Medical Group earned a net margin of 8.6% in FY 2025, up from -4.9% a year earlier. Return on equity reached 19.1%, meaning Pediatrix Medical Group generated 0.19 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.69 versus 0.81 the year before, and the current ratio was 1.66.

At the end of FY 2025, MD traded at 11.0 times earnings; across the 6 fiscal years shown, its year-end P/E ranged from 11.0 to 19.1, with a median of 16.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Pediatrix Medical Group financial ratios (annual)

Pediatrix Medical Group annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)10.97——18.8117.78——11.2515.4919.10
Price / sales0.940.540.380.631.211.181.271.741.521.94
Price / book2.081.430.901.392.572.741.510.971.612.23
Operating margin10.9%-3.4%0.4%8.8%10.6%5.7%9.7%14.4%14.0%18.0%
Net margin8.6%-4.9%-3.0%3.4%6.9%-45.9%-84.2%15.6%9.8%10.2%
Free cash flow margin13.2%9.2%5.2%7.0%2.3%10.1%19.0%17.2%14.9%12.7%
Return on equity (ROE)19.1%-13.0%-7.1%7.4%14.6%-106.6%-99.9%8.7%10.4%11.8%
Return on assets (ROA)7.4%-4.6%-2.7%2.8%4.8%-23.8%-36.1%4.5%5.5%6.1%
Debt / equity0.690.810.750.731.112.271.130.640.600.62
Current ratio1.661.471.241.001.973.491.351.311.181.31
Revenue growth-4.9%0.9%1.1%3.2%10.2%-2.6%3.3%-47.0%2.2%14.5%
EPS growth——-192.4%-48.4%——-708.5%-15.1%-1.1%-2.5%

Related